The first volunteer due for injection with Israel’s coronavirus vaccine says he is feeling optimistic, and described his participation in the trial as “a historic opportunity.”
Clinical trials for the Brilife vaccine, developed by the Israel Institute for Biological Research, start Sunday at Sheba Medical Center in Ramat Gan and at Hadassah Medical Center in Jerusalem.
“I think everything will be ok, I’m even sure of it,” says Segev Harel, a 26-year-old undergraduate student from Kibbutz Sde Nehemia in northern Israel, introducing himself as the first Israeli due to receive a shot in a video released by Sheba Medical Center.
Segev Harel, set to receive the first shot of Israel’s vaccine candidate. (Sheba Medical Center)
Speaking in a video shot by a friend, he says he is healthy and feels confident about the test.
“A lot of people have been harmed by coronavirus, health-wise, psychologically and economically. And if the small contribution I can make is to participate in this trial and give hope that we’re on the way to end the plague, I’ll have played my part,” he says.
-Nathan Jeffay
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel
From the Liveblog of
Saturday, October 31, 2020
Add ToI as a Preferred Source on Google
